Comparison and Correlation of Genetic Variability of the HBV Pre-S Region in HIV/HBV Co-Infected Patients: Quasispecies Perspective

References

• Kourtis AP, Bulterys M, Hu DJ, et al. HIV–HBV Coinfection — A Global Challenge. N Engl J Med. 2012;366(19):1749–1752. doi:10.1056/NEJMp120179622571198
   PubMed Web of Science ®Google Scholar
• Zhang F, Zhu H, Wu Y, et al. HIV, hepatitis B virus, and hepatitis C virus co-infection in patients in the China National Free Antiretroviral Treatment Program, 2010–12: a retrospective observational cohort study. Lancet Infect Dis. 2014;14(11):1065–1072. doi:10.1016/S1473-3099(14)70946-625303841
   PubMed Web of Science ®Google Scholar
• Tanday S. HBV and HCV co-infection increases cancer risk in HIV patients[J]. Lancet Oncol. 2016;17(11):e484. doi:10.1016/S1470-2045(16)30512-527773486
   PubMed Web of Science ®Google Scholar
• RODRIGUEZ-FRIAS F, et al. Quasispecies structure, cornerstone of hepatitis B virus infection: mass sequencing approach[J]. World J Gastroenterol. 2013;19(41):6995–7023. doi:10.3748/wjg.v19.i41.699524222943
   PubMed Web of Science ®Google Scholar
• Jazayeri SM, Alavian SM, Carman WF. Hepatitis B virus: origin and evolution[J]. J Viral Hepat. 2010;17(4):229–235. doi:10.1111/j.1365-2893.2009.01193.x20002567
   PubMed Web of Science ®Google Scholar
• Domingo E, Gomez J. Quasispecies and its impact on viral hepatitis[J]. Virus Res. 2007;127(2):131–150. doi:10.1016/j.virusres.2007.02.00117349710
   PubMed Web of Science ®Google Scholar
• Liu F, Chen L, Yu Dm, et al. Evolutionary patterns of hepatitis B virus quasispecies under different selective pressures: correlation with antiviral efficacy[J]. Gut. 2011;60(9):1269–1277. doi:10.1136/gut.2010.22622521292683
   PubMed Web of Science ®Google Scholar
• Yang Z-T, Huang S-Y, Chen L, et al. Characterization of Full-Length Genomes of Hepatitis B Virus Quasispecies in Sera of Patients at Different Phases of Infection[J]. J Clin Microbiol. 2015;53(7):2203–2214. doi:10.1128/JCM.00068-1525926495
   PubMed Web of Science ®Google Scholar
• Desmond CP, Bartholomeusz A, Gaudieri S, et al. A systematic review of T-cell epitopes in hepatitis B virus: identification, genotypic variation and relevance to antiviral therapeutics[J]. Antivir Ther. 2008;13(2):161–175.18505168
   PubMed Web of Science ®Google Scholar
• Li X, Qin Y, Liu Y, et al. PreS deletion profiles of hepatitis B virus (HBV) are associated with clinical presentations of chronic HBV infection[J]. J Clin Virol. 2016;82:27–32. doi:10.1016/j.jcv.2016.06.01827415434
   PubMed Web of Science ®Google Scholar
• Chen BF, Liu CJ, Jow GM, et al. High prevalence and mapping of pre-S deletion in hepatitis B virus carriers with progressive liver diseases[J]. Gastroenterology. 2006;130(4):1153–1168. doi:10.1053/j.gastro.2006.01.01116618410
   PubMed Web of Science ®Google Scholar
• Li KW, Kramvis A, Liang S, et al. Higher prevalence of cancer related mutations 1762T/1764A and PreS deletions in hepatitis B virus (HBV) isolated from HBV/HIV co-infected compared to HBV-mono-infected Chinese adults[J]. Virus Res. 2017;227:88–95. doi:10.1016/j.virusres.2016.10.00227720823
   PubMed Web of Science ®Google Scholar
• Audsley J, Littlejohn M, Yuen L, et al. HBV mutations in untreated HIV-HBV co-infection using genomic length sequencing[J]. Virology. 2010;405(2):539–547. doi:10.1016/j.virol.2010.06.03820655563
   PubMed Web of Science ®Google Scholar
• Tamura K, Stecher G, Peterson D, et al. MEGA6: molecular Evolutionary Genetics Analysis version 6.0[J]. Mol Biol Evol. 2013;30(12):2725–2729. doi:10.1093/molbev/mst19724132122
   PubMed Web of Science ®Google Scholar
• Tamura K, Peterson D, Peterson N, et al. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods[J]. Mol Biol Evol. 2011;28(10):2731–2739. doi:10.1093/molbev/msr12121546353
   PubMed Web of Science ®Google Scholar
• Ali MS, Groenwold RHH, Belitser SV, et al. Reporting of covariate selection and balance assessment in propensity score analysis is suboptimal: a systematic review[J]. J Clin Epidemiol. 2015;68(2):112–121. doi:10.1016/j.jclinepi.2014.08.01125433444
   PubMed Web of Science ®Google Scholar
• Maracy MR, Mostafaei S, Moghoofei M, et al. Impact of HIV risk factors on survival in Iranian HIV-infected patients: A Bayesian approach to retrospective cohort[J]. HIV AIDS Rev. 2017;2:100–106. doi:10.5114/hivar.2017.68117
   Google Scholar
• Cassino L, Laufer N, Salomon H, et al. Hepatitis B precore/core promoter mutations in isolates from HBV-monoinfected and HBV–HIV coinfected patients: A 3-yr prospective study. J Clin Virol. 2009;46(4):354–359. doi:10.1016/j.jcv.2009.09.01519800842
   PubMed Web of Science ®Google Scholar
• Mondal RK, Khatun M, Ghosh S, et al. Immune-driven adaptation of hepatitis B virus genotype D involves preferential alteration in B-cell epitopes and replicative attenuation—an insight from human immunodeficiency virus/hepatitis B virus coinfection. Clin Microbiol Infect. 2015;21(7):710–711. doi:10.1016/j.cmi.2015.03.004
   Google Scholar
• Shen T. Hepatitis B virus genetic mutations and evolution in liver diseases[J]. World J Gastroenterol. 2014;20(18):5435–5441. doi:10.3748/wjg.v20.i18.543524833874
   PubMed Web of Science ®Google Scholar
• Moghoofei M, Bokharaei-Salim F, Esghaei M, et al. microRNAs 29, 150, 155, 223 level and their relation to viral and immunological markers in HIV-1 infected naive patients[J]. Future Virol. 2018;13(9):637–645. doi:10.2217/fvl-2018-0055
   Web of Science ®Google Scholar
• Yousefpouran S, Mostafaei S, Manesh PV. The assessment of selected MiRNAs profile in HIV, HBV, HCV, HIV/HCV, HIV/HBV Co-infection and elite controllers for determination of biomarker. Microb Pathog. 2020;147:104355. doi:10.1016/j.micpath.2020.10435532569788
   PubMed Web of Science ®Google Scholar
• Etzerodt A, Moestrup Sk. CD163 and inflammation: biological, diagnostic, and therapeutic aspects[J]. Antioxid Redox Signal. 2013;18(17):2352–2363. doi:10.1089/ars.2012.483422900885
   PubMed Web of Science ®Google Scholar
• Hiraoka A, Horiike N, Akbar SMF, et al. Soluble CD163 in patients with liver diseases: very high levels of soluble CD163 in patients with fulminant hepatic failure[J]. J Gastroenterol. 2005;40(1):52–56. doi:10.1007/s00535-004-1493-815692789
   PubMed Web of Science ®Google Scholar
• Campbell JH, Hearps AC, Martin GE, et al. The importance of monocytes and macrophages in HIV pathogenesis, treatment, and cure[J]. AIDS. 2014;28(15):2175–2187. doi:10.1097/QAD.000000000000040825144219
   PubMed Web of Science ®Google Scholar
• Migita K, Sawakami-Kobayashi K, Maeda Y, et al. Interleukin-18 promoter polymorphisms and the disease progression of Hepatitis B virus-related liver disease[J]. Transl Res. 2009;153(2):91–96. doi:10.1016/j.trsl.2008.11.00819138654
   PubMed Web of Science ®Google Scholar
• Kimura K, Kakimi K, Wieland S, et al. Interleukin-18 inhibits hepatitis B virus replication in the livers of transgenic mice[J]. J Virol. 2002;76(21):10702–10707. doi:10.1128/JVI.76.21.10702-10707.200212368312
   PubMed Web of Science ®Google Scholar
• Lee M-O, Choi Y-H, Shin E-C, et al. Hepatitis B virus X protein induced expression of interleukin 18 (IL-18): a potential mechanism for liver injury caused by hepatitis B virus (HBV) infection[J]. J Hepatol. 2002;37(3):380–386. doi:10.1016/S0168-8278(02)00181-212175634
   PubMed Web of Science ®Google Scholar
• Li Y, Xie J, Wang H, et al. Elevated pre-treatment IL-18 level is associated with HBeAg seroconversion in HIV–HBV coinfection. Antivir Ther. 2017;22(6):523–527. doi:10.3851/IMP313628195558
   PubMed Web of Science ®Google Scholar
• Liu R, Guo J, Lu Y, et al. Changes in APRI and FIB-4 in HBeAg-negative treatment-naive chronic hepatitis B patients with significant liver histological lesions receiving 5-year entecavir therapy[J]. Clin Exp Med. 2019;19(3):309–320. doi:10.1007/s10238-019-00560-z31111345
   PubMed Web of Science ®Google Scholar
• Laffi G, Marra F, Gresele P, et al. Evidence for a storage pool defect in platelets from cirrhotic patients with defective aggregation[J]. Gastroenterology. 1992;103(2):641–646.1386051
   PubMed Web of Science ®Google Scholar